(Q53538160)

English

Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.

scientific article published on 26 July 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. (English)

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Emmet McCormack

3

object named as

Emmet McCormack

0 references

Bjørn Tore Gjertsen

7

object named as

Bjørn Tore Gjertsen

1 reference

Europe PubMed Central

15 May 2018

author name string

Elisabeth Ersvaer

1

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

Jian-Ying Zhang

2

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

Emmet McCormack

3

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

Astrid Olsnes

4

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

Nina Anensen

5

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

Eng M Tan

6

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

Oystein Bruserud

8

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

publication date

26 July 2007

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

European Journal of Haematology

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

79

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

3

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

210-225

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Immunogenicity of Bcl-2 in patients with cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

The decision to enter mitosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

The localization of human cyclins B1 and B2 determines CDK1 substrate specificity and neither enzyme requires MEK to disassemble the Golgi apparatus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Temporal and spatial control of cyclin B1 destruction in metaphase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Detection of cyclin b1 expression in g(1)-phase cancer cell lines and cancer tissues by postsorting Western blot analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Regulation of the G2/M transition by p53.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

p53-dependent gene profiling for reactive oxygen species after benzene inhalation: special reference to genes associated with cell cycle regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

MPF localization is controlled by nuclear export

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Overexpression of cyclin B1 in human colorectal cancers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Biological treatment in acute myelogenous leukaemia: how should T-cell targeting immunotherapy be combined with intensive chemotherapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Clonal selection and learning in the antibody system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Development of a whole cell vaccine for acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2007.00899.X

21 January 2018

Identifiers

10.1111/J.1600-0609.2007.00899.X

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17655707

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53538160&oldid=1240699495"